Corticosteroids for all adult patients with community-acquired pneumonia?
<p>Corticosteroid therapy as adjunctive treatment in community-acquired pneumonia (CAP) is a promising but controversial subject. The potentially beneficial effect of corticosteroids is based on the ability of steroids to dampen an excessive inflammatory response that often occurs in patients...
Main Authors: | Ger Rijkers, Simone Spoorenberg, Stefan Vestjens, Werner Albrich |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2015-01-01
|
Series: | Pneumonia |
Subjects: | |
Online Access: | https://pneumonia.org.au/index.php/pneumonia/article/view/690 |
Similar Items
-
Adjuvant Inhaled Corticosteroids in Community-Acquired Pneumonia: A Review Article
by: Faeq R. Kukhon, et al.
Published: (2021-05-01) -
Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia
by: Antoni Torres, et al.
Published: (2019-09-01) -
Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia
by: Masato Tashiro, et al.
Published: (2017-12-01) -
The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis
by: Yue-Nan Ni, et al.
Published: (2019-03-01) -
Clinical outcome of patients with COVID-19 Pneumonia treated with corticosteroids and colchicine in Colombia
by: Miguel Alejandro Pinzón, et al.
Published: (2021-09-01)